Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |